Biomatter

Biomatter is a Vilnius-based synthetic biology company that designs custom enzymes with generative AI, creating them from the target chemistry up rather than by modifying natural enzymes. Its Intelligent Architecture platform pairs AI enzyme design with in-house lab testing, cutting development cycles from months or years down to weeks. Founded in 2018, the company has delivered more than 50 custom enzymes to over 25 enterprise customers, including AstraZeneca, BASF, Sanofi and Thermo Fisher Scientific, spanning biopharma, diagnostics, agriculture and industrial biotech across Europe, the US and Japan.

  • B2B
  • Series A
  • Generative AI
  • Biotechnology
  • Synthetic Biology
  • Healthcare & Life Sciences

1

Round

1

Industry

5

Tags

Nov 12, 2026

Latest raise

Funding activity · 1 round

Raise timeline

  1. Nov 12, 2026

    $18M

    Series A

    Led by Astanor

    • Metaplanet Holdings
    • Inventure
    • UVC Partners
    • Astanor

    Article coming soon.

Pricing

Research Biomatter — then scale the playbook

Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.

Enterprise

Custom pricing for unlimited scale. Let's talk.

Contact sales

Growth plan

For individuals and small teams getting started with AI buyer intelligence.

$149

/month

Features

  • Access to core AI adoption signals
  • 3–5 curated slices per week
  • 30–60 companies / week
  • AI Adoption Score
  • Deal-ready insights (why + pitch angle)
  • Basic filters (recency, slice, score)
  • CSV export
Most popular

Pro plan

For outbound teams and agencies that need more coverage and faster signal cadence.

$249

/month

Features

  • Everything in Growth, plus:
  • Full access to all slices
  • 60–120 companies / week
  • Higher-frequency signal updates
  • Priority / early signals (before Growth)
  • Advanced filters (industry, size, use case)
  • Deeper company insights
  • Faster export + bulk workflows

Act on this raise

See if Biomatter is moving on AI

Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.

© 2026 VeilStrat. All rights reserved.All systems operational